| Key Financial Ratios of OXYGENTA PHARMACEUTICAL (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
-2.69 |
-1.09 |
-8.15 |
-0.48 |
2.87 |
|
| Diluted EPS (Rs.) |
-2.69 |
-1.04 |
-8.15 |
-0.48 |
2.87 |
|
| Cash EPS (Rs.) |
-2.40 |
-0.24 |
-6.70 |
0.69 |
4.04 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
-6.77 |
-6.01 |
-32.53 |
-24.38 |
-37.27 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
-6.77 |
-6.01 |
-32.53 |
-24.38 |
-37.27 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
29.55 |
11.84 |
21.82 |
42.62 |
51.00 |
|
| PBDIT/Share (Rs.) |
-2.35 |
-2.88 |
-5.00 |
1.04 |
3.86 |
|
| PBIT/Share (Rs.) |
-2.57 |
-3.68 |
-6.44 |
-0.08 |
2.68 |
|
| PBT/Share (Rs.) |
-3.12 |
-4.14 |
-8.01 |
-0.34 |
3.08 |
|
| Net Profit/Share (Rs.) |
-2.62 |
-1.04 |
-8.15 |
-0.43 |
2.87 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
-7.94 |
-24.35 |
-22.90 |
2.44 |
7.56 |
|
| PBIT Margin (%) |
-8.69 |
-31.06 |
-29.53 |
-0.18 |
5.26 |
|
| PBT Margin (%) |
-10.57 |
-34.99 |
-36.70 |
-0.80 |
6.04 |
|
| Net Profit Margin (%) |
-8.85 |
-8.77 |
-37.34 |
-1.00 |
5.63 |
|
| Return on Networth / Equity (%) |
0.00 |
0.00 |
0.00 |
0.00 |
-7.70 |
|
| Return on Capital Employed (%) |
391.43 |
-41.74 |
-37.43 |
-0.47 |
16.72 |
|
| Return on Assets (%) |
-11.60 |
-5.50 |
-21.32 |
-1.95 |
8.65 |
|
| Total Debt/Equity (X) |
-2.49 |
-2.84 |
-1.47 |
-1.51 |
-1.26 |
|
| Asset Turnover Ratio (%) |
1.49 |
0.68 |
0.73 |
1.86 |
153.63 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
0.36 |
0.72 |
0.84 |
1.19 |
0.91 |
|
| Quick Ratio (X) |
0.12 |
0.31 |
0.45 |
0.28 |
0.22 |
|
| Inventory Turnover Ratio (X) |
6.39 |
2.76 |
2.96 |
4.40 |
4.29 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
356.35 |
154.20 |
119.86 |
86.13 |
54.89 |
|
| EV/Net Operating Revenue (X) |
3.26 |
3.89 |
3.87 |
1.42 |
1.06 |
|
| EV/EBITDA (X) |
-41.03 |
-15.97 |
-16.88 |
58.17 |
13.95 |
|
| MarketCap/Net Operating Revenue (X) |
2.69 |
2.45 |
1.68 |
0.56 |
0.14 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
-11.76 |
-4.82 |
-1.13 |
-0.99 |
-0.20 |
|
| Price/Net Operating Revenue |
2.69 |
2.45 |
1.68 |
0.56 |
0.14 |
|
| Earnings Yield |
-0.03 |
-0.04 |
-0.22 |
-0.02 |
0.39 |
|
Source : Dion Global Solutions Limited
